dexcom inc (DXCM:NASDAQ GS)
Andrew K. Balo
Senior Vice President of Clinical & Regulatory Affairs, DexCom, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Andrew K. Balo, also known as Andy, serves as Vice President of Regulatory and Clinical Affairs at Post-Hypothermia Corporation. Mr. Balo has been Senior Vice President of Clinical & Regulatory Affairs at Dexcom, Inc. since March 2008. He oversees all of Dexcom's clinical trials, statistical analyses, and regulatory submissions. He is an industry expert in regulatory strategies and sits on several FDA panels including cardiovascular, neurological and gastrointestinal ...
6340 Sequence DrivePhone: 858-200-0200
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
University of Maryland
University of California-Los Angeles
The Leland Stanford Junior University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Justin C. Dearborn||Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA|
Merge Healthcare Incorporated
|Eyal Shalom||Chief Executive Officer|
RadView Software Ltd.
|Lisa A. Hook||Chief Executive Officer, President, Director and Member of Neutrality Committee|
|Duane DeSisto||Chief Executive Officer, President and Director|
|Kim D. Blickenstaff||Chief Executive Officer, President and Director|
Tandem Diabetes Care, Inc.
|$472.1K||Compensation as of Fiscal Year 2013.|